Literature DB >> 9378013

Relationship between glucocorticoid receptor and response to glucocorticoid therapy in ulcerative colitis.

T Shimada1, N Hiwatashi, H Yamazaki, Y Kinouchi, T Toyota.   

Abstract

PURPOSE: To clarify the relationship between the glucocorticoid receptor and the effectiveness of glucocorticoid therapy in patients with ulcerative colitis, we investigated the number and apparent dissociation constant of glucocorticoid receptor in peripheral blood mononuclear leukocytes of patients with ulcerative colitis.
MATERIALS AND METHODS: Eleven patients with ulcerative colitis (5 who responded to intravenous glucocorticoids and 6 who did not) and ten control subjects were studied. The number and apparent dissociation constant of glucocorticoid receptor were measured using a whole-cell binding assay. Results were expressed as a median (interquartile range).
RESULTS: The number of glucocorticoid receptors from the six nonresponders, five responders, and ten healthy controls were 4922 (range, 4484-5643), 3413 (range, 3183-4450), and 3610 (range, 2594-3979) binding sites/cell, respectively. The apparent dissociation constant of the glucocorticoid receptors from the nonresponders, responders, and healthy controls were 7.03 (range, 5.66-10), 4.27 (range, 4-5.13), and 6.18 (range, 5.86-6.74) nM, respectively. Nonresponders had a significant increase both in the number of binding sites and in the apparent dissociation constant compared with responders (P = 0.045; P = 0.029).
CONCLUSIONS: The increased number and apparent dissociation constant of glucocorticoid receptor are closely associated with the effectiveness of glucocorticoid therapy. The measurement of the number and apparent dissociation constant of glucocorticoid receptor may be useful in predicting response to glucocorticoids.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9378013     DOI: 10.1007/bf02062021

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  6 in total

Review 1.  Glucocorticoid sensitivity in health and disease.

Authors:  Rogier A Quax; Laura Manenschijn; Jan W Koper; Johanna M Hazes; Steven W J Lamberts; Elisabeth F C van Rossum; Richard A Feelders
Journal:  Nat Rev Endocrinol       Date:  2013-10-01       Impact factor: 43.330

2.  Age, body mass index, and serum level of DHEA-S can predict glucocorticoid receptor function in women with polycystic ovary syndrome.

Authors:  Djuro Macut; Danijela Vojnović Milutinović; Ivana Božić; Gordana Matić; Jelena Brkljačić; Dimitrios Panidis; Milan Petakov; Nikolaos Spanos; Jelica Bjekić; Olivera Stanojlović; Anđela Petrović Milinković; Zoran Radojičić; Svetozar Damjanović
Journal:  Endocrine       Date:  2009-11-17       Impact factor: 3.633

3.  Pulse cyclophosphamide therapy for inflammatory bowel disease.

Authors:  Zsolt Barta; László Tóth; Margit Zeher
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

4.  Flow cytometry analysis of glucocorticoid receptor expression and binding in steroid-sensitive and steroid-resistant patients with systemic lupus erythematosus.

Authors:  Juan Du; Min Li; Denghai Zhang; Xiaoyan Zhu; Weiwei Zhang; Wei Gu; Yinglu Feng; Xiaofeng Zhai; Changquan Ling
Journal:  Arthritis Res Ther       Date:  2009-07-14       Impact factor: 5.156

5.  Expression of glucocorticoid receptors in mononuclear cells in nephrotic syndrome.

Authors:  Anna Wasilewska; Walentyna Zoch-Zwierz; Barbara Tomaszewska; Ryszard Wierciński; Anna Stasiak-Barmuta
Journal:  Pediatr Nephrol       Date:  2003-06-12       Impact factor: 3.714

Review 6.  Mesoporous Materials as Elements of Modern Drug Delivery Systems for Anti-Inflammatory Agents: A Review of Recent Achievements.

Authors:  Michał Moritz; Małgorzata Geszke-Moritz
Journal:  Pharmaceutics       Date:  2022-07-25       Impact factor: 6.525

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.